Showing results (481-490 of 519) with videos related to
Sort By:
Pageof 52
Blood|March 23, 2006
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)Tadeusz Robak, Jerzy Z Blonski, Joanna Gora-Tybor, et al.The Pan African Medical Journal|March 9, 2018
[Occult hepatitis B reactivation in a patient with homozygous sickle cell disease: clinical case and literature review]Moustapha Diop, Viviane Marie Pierre Cisse-Diallo, Daye Ka, et al.BMJ Open|March 2, 2026
ReFIT study (reversing frailty in transplantation): protocol for a longitudinal study to assess clinical and biomedical changes in frailty through kidney transplantationTrent Payne, Alyra Shaw, Leila Shafiee Hanjani, et al.Scientific Reports|December 9, 2021
Emergence of novel combinations of SARS-CoV-2 spike receptor binding domain variants in SenegalAmbroise D Ahouidi, Mary A Rodgers, Abdou Padane, et al.Physics and Imaging in Radiation Oncology|October 6, 2021
In-vivo X-ray dark-field computed tomography for the detection of radiation-induced lung damage in miceRico Burkhardt, Thomas Gora, Alexander A Fingerle, et al.The Journal of Biological Chemistry|February 25, 2023
Gβγ subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblastsShahriar M Khan, Ryan D Martin, Andrew Bayne, et al.Medecine Sciences : M/S|May 23, 2019
[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]Damien Cohen, Yusuke Shimakawa, Gibril Ndow, et al.Physics and Imaging in Radiation Oncology|January 18, 2021
Inter-centre variability of CT-based stopping-power prediction in particle therapy: Survey-based evaluationVicki T Taasti, Christian Bäumer, Christina V Dahlgren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study)Tadeusz Robak, Krzysztof Jamroziak, Joanna Gora-Tybor, et al.Scientific Data|November 29, 2024
Air quality and transport behaviour: sensors, field, and survey data from Warsaw, PolandAmirhossein Hassani, Anna Nicińska, Arkadiusz Drabicki, et al.Pageof 52